Schedule 13G ownership disclosure

ENVERIC BIOSCIENCES INC

Common Stock, $0.01 par value per share · CUSIP: 29405E505

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Ayrton Capital LLC

    Shares: 658,465.00 · Class: 9.99%

  • Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B

    Shares: 658,465.00 · Class: 9.99%

  • Waqas Khatri

    Shares: 658,465.00 · Class: 9.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-25-022260
Form type
SCHEDULE 13G
Filer
Ayrton Capital LLC
CIK
CIK 1698148
Filed
Nov 13, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub

SCHEDULE 13G | SEC Filings Hub